Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 11Unknown 6Recruiting 6Terminated 3Not yet recruiting 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 2Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1Leukemia 1Breast Neoplasms 1Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Carboplatin 127Cisplatin 125Drug Therapy 116Bevacizumab 102Capecitabine 100Oxaliplatin 99Radiotherapy 97Gemcitabine 87tislelizumab 86Paclitaxel 86Cyclophosphamide 85pembrolizumab 77Specimen Handling 77toripalimab 70Magnetic Resonance Spectroscopy 63Injections 63Fluorouracil 63sintilimab 58Surgical Procedures, Operative 58anlotinib 53Docetaxel 52130-nm albumin-bound paclitaxel 51fludarabine 47Standard of Care 45Pemetrexed 45Immune Checkpoint Inhibitors 45Blood Specimen Collection 43venetoclax 42Leucovorin 42lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Anthracyclines × Clear all
NCT07060001 2026-03-06

Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker

The Methodist Hospital Research Institute

Phase 2 Not yet recruiting
112 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT07317778 2026-01-05

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
249 enrolled
Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT06684054 2024-11-12

STFREiYTNBC

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Not yet recruiting
30 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡